The Ensign Group, Inc. faces multiple securities class-action lawsuits brought by Rosen Law Firm and Kaplan Fox & Kilsheimer LLP on behalf of investors. [3, 5] The lawsuits allege that the company made materially false and misleading statements between February 2022 and June 2026 about its quality of care and regulatory compliance. [12]
The legal actions follow a June 2026 report by an investigative outlet alleging systemic problems with patient care and data misrepresentation. [5]
The lawsuits seek damages for investors who purchased the company’s securities during the class period. Investors have until December 7, 2026, to ask the court to appoint them as lead plaintiff. [6]